Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial S McCormack, DT Dunn, M Desai, DI Dolling, M Gafos, R Gilson, ... The Lancet 387 (10013), 53-60, 2016 | 2124 | 2016 |
Chemsex behaviours among men who have sex with men: a systematic review of the literature S Maxwell, M Shahmanesh, M Gafos International Journal of Drug Policy 63, 74-89, 2019 | 435 | 2019 |
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial S McCormack, G Ramjee, A Kamali, H Rees, AM Crook, M Gafos, ... The Lancet 376 (9749), 1329-1337, 2010 | 393 | 2010 |
A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme R Pool, CM Montgomery, NS Morar, O Mweemba, A Ssali, M Gafos, ... PloS one 5 (7), e11600, 2010 | 106 | 2010 |
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial AR Miltz, FC Lampe, LJ Bacchus, S McCormack, D Dunn, E White, ... BMC public health 19, 1-17, 2019 | 83 | 2019 |
Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten … A South, B Hanley, M Gafos, B Cromarty, R Stephens, K Sturgeon, K Scott, ... Trials 17, 1-13, 2016 | 78 | 2016 |
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis DI Dolling, M Desai, A McOwan, R Gilson, A Clarke, M Fisher, G Schembri, ... Trials 17, 1-11, 2016 | 77 | 2016 |
Microbicide clinical trial adherence: insights for introduction C Woodsong, K MacQueen, KR Amico, B Friedland, M Gafos, L Mansoor, ... African Journal of Reproduction and Gynaecological Endoscopy 16 (1), 2013 | 76 | 2013 |
Re-framing microbicide acceptability: findings from the MDP301 trial CM Montgomery, M Gafos, S Lees, NS Morar, O Mweemba, A Ssali, ... Culture, health & sexuality 12 (6), 649-662, 2010 | 76 | 2010 |
The context of sexual risk behaviour among men who have sex with men seeking PrEP, and the impact of PrEP on sexual behaviour M Gafos, R Horne, W Nutland, G Bell, C Rae, S Wayal, M Rayment, ... AIDS and Behavior 23, 1708-1720, 2019 | 73 | 2019 |
Healthcare providers' knowledge of, attitudes to and practice of pre‐exposure prophylaxis for HIV infection M Desai, M Gafos, D Dolling, S McCormack, A Nardone, PROUD study HIV medicine 17 (2), 133-142, 2016 | 68 | 2016 |
Alcohol availability, marketing, and sexual health risk amongst urban and rural youth in South Africa L Letsela, R Weiner, M Gafos, K Fritz AIDS and Behavior 23, 175-189, 2019 | 65 | 2019 |
Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use M Gafos, M Mzimela, S Sukazi, R Pool, C Montgomery, J Elford Culture, health & sexuality 12 (8), 929-942, 2010 | 61 | 2010 |
The impact of gender norms on condom use among HIV-positive adults in KwaZulu-Natal, South Africa K Fladseth, M Gafos, ML Newell, N McGrath PLoS One 10 (4), e0122671, 2015 | 58 | 2015 |
Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model R Pool, CM Montgomery, NS Morar, O Mweemba, A Ssali, M Gafos, ... PloS one 5 (7), e11632, 2010 | 58 | 2010 |
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial AM Crook, D Ford, M Gafos, R Hayes, A Kamali, S Kapiga, A Nunn, ... Human reproduction 29 (8), 1810-1817, 2014 | 53 | 2014 |
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants C O'Halloran, B Rice, E White, M Desai, DT Dunn, S McCormack, ... International Journal of Drug Policy 74, 246-254, 2019 | 52 | 2019 |
Chemsex-related drug use and its association with health outcomes in men who have sex with men: a cross-sectional analysis of Antidote clinic service data O Stevens, M Moncrieff, M Gafos Sexually Transmitted Infections 96 (2), 124-130, 2020 | 51 | 2020 |
Pre-exposure prophylaxis use and medication adherence among men who have sex with men: a systematic review of the literature S Maxwell, M Gafos, M Shahmanesh Journal of the Association of Nurses in AIDS Care 30 (4), e38-e61, 2019 | 44 | 2019 |
Risk compensation and STI incidence in PrEP programmes: Latest evidence and research gaps M Quaife, LW Macgregor, J Ong, M Gafos, S Torres-Rueda, H Grant, ... Lancet HIV, 2019 | 39 | 2019 |